Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled

Andrea Henkel1, Erica P Cahill, Sonia Chavez

  • 1Division of Family Planning Services and Research and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford University School of Medicine, and Stanford Health Care, Palo Alto, and Planned Parenthood Mar Monte, San Jose, California.

Obstetrics and Gynecology
|January 15, 2026
PubMed
Summary

Cabergoline effectively prevents lactation symptoms after early second-trimester pregnancy loss or abortion. This well-tolerated medication significantly reduced breast symptoms and bother compared to placebo.